Orbital Therapy debuts artifact-reducing insert for breast imaging

Breast cancer technology provider Orbital Therapy has announced the availability of its artifact-reducing insert for its ClearVue prone breast platform.

According to the Bedford, Mass.-based company, the patent-pending design of the new insert reduces the shadow effect projected through the breast to be treated, generated by the CT reconstruction process, resulting in a cleaner CT image of the breast.

 

Around the web

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.